Protective effect of augmenter of liver regeneration on vincristine-induced cell death in Jurkat T leukemia cells

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 162-167

  Shen, Yan ^a   Liu, Qi ^a   Sun, Hang ^a   Li, Xiaofang ^a   Wang, Na ^a   Guo, Hui ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Acute T lymphoblastic leukemia incristine; Anti apoptosis; Augmenter of liver regeneration

Indexed keywords

AUGMENTER OF LIVER REGENERATION ENZYME; CASPASE 3; CASPASE 8; PROTEIN BCL 2; THIOL OXIDASE; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER GROWTH; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIVER REGENERATION; PRIORITY JOURNAL;

ACUTE T LYMPHOBLASTIC LEUKEMIA; ANTI-APOPTOSIS; AUGMENTER OF LIVER REGENERATION; VINCRISTINE;

CASPASE 3; CASPASE 8; CELL DEATH; CYTOPROTECTION; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; LIVER REGENERATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; VINCRISTINE;

EID: 84880183182     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.030     Document Type: Article

References (40)

1. Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2010;24:1-18.
2. Pui CH. Recent advances in acute lymphoblastic leukemia. Oncology (Williston Park) 2011;25(341):6-7.
3. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24: 265-84.
4. Indran IR, Tufo G, Pervaiz S, Brenner C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta 1807;2011: 735-45.
5. Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 1994;19:26-30. (Pubitemid 24028728)
6. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994;91:8142-6. (Pubitemid 24253902)
7. Polimeno L, Pesetti B, Annoscia E, Giorgio F, Francavilla R, Lisowsky T, et al. Alrp, a survival factor that controls the apoptotic process of regenerating liver after partial hepatectomy in rats. Free Radic Res 2011;45:534-49.
8. Yu HY, Xiang DR, Huang HJ, Li J, Sheng JF. Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2010;9:492-8.
9. Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005;47:57-66. (Pubitemid 40978814)
10. Tzirogiannis KN, Papadimas GK, Kourentzi KT, Kondili VG, Androutsos CD, Hereti RI, et al. The role of hepatic stimulator substance (HSS) on liver regeneration arrest induced by cadmium. In Vivo 2005;19:695-704. (Pubitemid 40903264)
11. Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000;35:112-9. (Pubitemid 30129002)
12. Polimeno L, Pesetti B, Lisowsky T, Iannone F, Resta L, Giorgio F, et al. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res 2009;43:865-75.
13. Liao XH, Zhang L, Liu Q, Sun H, Peng CM, Guo H. Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol Dial Transplant 2010;25:2921-9.
14. Ilowski M, Kleespies A, de Toni EN, Donabauer B, Jauch KW, Hengstler JG, et al. Augmenter of liver regeneration (ALR) protects human hepatocytes against apoptosis. Biochem Biophys Res Commun 2011;404:148-52.
15. Sun H, Yu HF, Wu CX, Guan XQ, Liu Q. Expression of augmenter of liver regeneration in hepatic tumor cells and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 2005;13:205-8.
16. Tang L, Sun H, Zhang L, Guo H, Liu Q. Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2. Ai Zheng 2006;25:671-6.
17. Tang L, Sun H, Zhang L, Guo H, Chen XH, Deng JC. Effects of anti-human augmenter of liver regeneration monoclonal antibody on proliferation of HepG2 cells in vitro. J Chongqing Med Univ 2005;30:7-9.
18. Gidding CE, Kellie SJ, Kamps WA, de Graaf SS. Vincristine revisited. Crit Rev Oncol Hematol 1999;29:267-87. (Pubitemid 29158972)
19. Jordan MA, Himes RH, Wilson L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res 1985;45:2741-7. (Pubitemid 15232744)
20. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 2003;22:15-20.
21. Yang BF, Xiao C, Li H, Yang SJ. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation. Clin Exp Pharmacol Physiol 2007;34:1245-51. (Pubitemid 350013235)
22. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-30. (Pubitemid 28133943)
23. Hou R, Zhou QL, Wang BX, Tashiro S, Onodera S, Ikejima T. Diosgenin induces apoptosis in HeLa cells via activation of caspase pathway. Acta Pharmacol Sin 2004;25:1077-82. (Pubitemid 39071117)
24. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 1999;274:22932-40.
25. Oliver FJ, Menissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 1999;64:1282-8. (Pubitemid 30468745)
26. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35: 495-516. (Pubitemid 46911891)
27. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6. (Pubitemid 27097313)
28. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999;274:1156-63.
29. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001;33: 173-80. (Pubitemid 32294181)
30. Yang X, Xie L, Qiu Z, Wu Z, He F. Human augmenter of liver regeneration: molecular cloning, biological activity and roles in liver regeneration. Sci China C Life Sci 1997;40:642-7. (Pubitemid 127489458)
31. Zhang YD, Zhou J, Zhao JF, Peng J, Liu XD, Liu XS, et al. Expression, purification and bioactivity of human augmenter of liver regeneration. World J Gastroenterol 2006;12:4401-5. (Pubitemid 44194537)
32. Tang L, Sun H, Zhang L, Deng JC, Guo H, Liu Q. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma. Saudi Med J 2009;30:1001-9.
33. Thirunavukkarasu C, Wang LF, Harvey SA, Watkins SC, Chaillet JR, Prelich J, et al. Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol 2008;48:578-88.
34. Li Y,Wei K, Lu C, Li M, Xing G,Wei H, et al. Identification of hepatopoietin dimerization, its interacting regions and alternative splicing of its transcription. Eur J Biochem 2002;269:3888-93. (Pubitemid 34994883)
35. Banci L, Bertini I, Cefaro C, Cenacchi L, Ciofi-Baffoni S, Felli IC, et al. Molecular chaperone function of Mia40 triggers consecutive induced folding steps of the substrate in mitochondrial protein import. Proc Natl Acad Sci U S A 2010;107: 20190-5.
36. Cao Y, Fu YL, Yu M, Yue PB, Ge CH, Xu WX, et al. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiationinduced oxidative stress. Free Radic Biol Med 2009;47:1057-66.
37. Todd LR, Damin MN, Gomathinayagam R, Horn SR, Means AR, Sankar U. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol Biol Cell 2010;21:1225-36.
38. Polimeno L, Pesetti B, De Santis F, Resta L, Rossi R, De Palma A, et al. Decreased expression of the augmenter of liver regeneration results in increased apoptosis and oxidative damage in human-derived glioma cells. Cell Death Dis 2012;3:e289.
39. Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996;2:97-108.
40. Lisowsky T. ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae. Curr Genet 1994;26:15-20. (Pubitemid 24192844)